| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |